Aspire Biopharma Holdings, Inc. (ASBP) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $7.69M | +355.5% |
| 2024 | $1.69M | +318.5% |
| 2023 | $403.3K | -96.4% |
| 2022 | $11.12M | +3684.8% |
| 2021 | $293.7K | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $7.69M | +355.5% |
| 2024 | $1.69M | +318.5% |
| 2023 | $403.3K | -96.4% |
| 2022 | $11.12M | +3684.8% |
| 2021 | $293.7K | — |